Peregrine Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Peregrine Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4M	Buy	+88,820	New	+$8.92M	0.34%	84

Other funds holding MIRM

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Peregrine Capital Management's MIRM Position: Q2 2026 in Review

Peregrine Capital Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 88,820 shares worth $10.4M. The stake represents 0.34% of the portfolio and ranks #84 among its holdings.

22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Peregrine Capital Management held 88,820 shares of Mirum Pharmaceuticals worth $10.4M as of Q2 2026.
Mirum Pharmaceuticals was a new Peregrine Capital Management position in Q2 2026.
Mirum Pharmaceuticals made up 0.34% of Peregrine Capital Management's portfolio in Q2 2026, its #84 holding.
22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.